Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Count...

por Oroujeni, Maryam, Abouzayed, Ayman, Lundmark, Fanny, Mitran, Bogdan, Orlova, Anna, Tolmachev, Vladimir, Rosenström, Ulrika
Publicado 2019

Affibody-mediated PET imaging of HER3 expression in malignant tumours

por Rosestedt, Maria, Andersson, Ken G., Mitran, Bogdan, Tolmachev, Vladimir, Löfblom, John, Orlova, Anna, Ståhl, Stefan
Publicado 2015

High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26

por Mitran, Bogdan, Thisgaard, Helge, Rosenström, Ulrika, Dam, Johan Hygum, Larhed, Mats, Tolmachev, Vladimir, Orlova, Anna
Publicado 2017

Preclinical Evaluation of [(68)Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors

por Oroujeni, Maryam, Garousi, Javad, Andersson, Ken G., Löfblom, John, Mitran, Bogdan, Orlova, Anna, Tolmachev, Vladimir
Publicado 2018

Evaluation of (99m)Tc-Z(IGF1R:4551)-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression

por Mitran, Bogdan, Altai, Mohamed, Hofström, Camilla, Honarvar, Hadis, Sandström, Mattias, Orlova, Anna, Tolmachev, Vladimir, Gräslund, Torbjörn
Publicado 2014

Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m

por Garousi, Javad, Lindbo, Sarah, Mitran, Bogdan, Buijs, Jos, Vorobyeva, Anzhelika, Orlova, Anna, Tolmachev, Vladimir, Hober, Sophia
Publicado 2017

Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with (99m)Tc using a peptide-based cysteine-containing chelator

por Andersson, Ken G., Oroujeni, Maryam, Garousi, Javad, Mitran, Bogdan, Ståhl, Stefan, Orlova, Anna, Löfblom, John, Tolmachev, Vladimir
Publicado 2016

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

por Abouzayed, Ayman, Yim, Cheng-Bin, Mitran, Bogdan, Rinne, Sara S., Tolmachev, Vladimir, Larhed, Mats, Rosenström, Ulrika, Orlova, Anna
Publicado 2019

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

por Mitran, Bogdan, Thisgaard, Helge, Rinne, Sara, Dam, Johan Hygum, Azami, Frishta, Tolmachev, Vladimir, Orlova, Anna, Rosenström, Ulrika
Publicado 2019

PET imaging of epidermal growth factor receptor expression in tumours using (89)Zr-labelled ZEGFR:2377 affibody molecules

por GAROUSI, JAVAD, ANDERSSON, KEN G., MITRAN, BOGDAN, PICHL, MARIE-LOUISE, STÅHL, STEFAN, ORLOVA, ANNA, LÖFBLOM, JOHN, TOLMACHEV, VLADIMIR
Publicado 2016

In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct

por Bass, Tarek Z., Rosestedt, Maria, Mitran, Bogdan, Frejd, Fredrik Y., Löfblom, John, Tolmachev, Vladimir, Ståhl, Stefan, Orlova, Anna
Publicado 2017

Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules

por Rinne, Sara S., Dahlsson Leitao, Charles, Saleh-nihad, Zahra, Mitran, Bogdan, Tolmachev, Vladimir, Ståhl, Stefan, Löfblom, John, Orlova, Anna
Publicado 2020

Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model

por Lundmark, Fanny, Abouzayed, Ayman, Mitran, Bogdan, Rinne, Sara S., Varasteh, Zohreh, Larhed, Mats, Tolmachev, Vladimir, Rosenström, Ulrika, Orlova, Anna
Publicado 2020

Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer

por Baun, Christina, Mitran, Bogdan, Rinne, Sara S., Dam, Johan H., Olsen, Birgitte B., Tolmachev, Vladimir, Orlova, Anna, Thisgaard, Helge
Publicado 2020

Development of an optimal imaging strategy for selection of patients for affibody-based PNA-mediated radionuclide therapy

por Vorobyeva, Anzhelika, Westerlund, Kristina, Mitran, Bogdan, Altai, Mohamed, Rinne, Sara, Sörensen, Jens, Orlova, Anna, Tolmachev, Vladimir, Karlström, Amelie Eriksson
Publicado 2018

Increase in negative charge of (68)Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

por Rinne, Sara S., Dahlsson Leitao, Charles, Gentry, Joshua, Mitran, Bogdan, Abouzayed, Ayman, Tolmachev, Vladimir, Ståhl, Stefan, Löfblom, John, Orlova, Anna
Publicado 2019

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

por Vorobyeva, Anzhelika, Bragina, Olga, Altai, Mohamed, Mitran, Bogdan, Orlova, Anna, Shulga, Alexey, Proshkina, Galina, Chernov, Vladimir, Tolmachev, Vladimir, Deyev, Sergey
Publicado 2018

Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of (68)Ga-Labeled Tracers

por Dahlsson Leitao, Charles, Rinne, Sara S., Mitran, Bogdan, Vorobyeva, Anzhelika, Andersson, Ken G., Tolmachev, Vladimir, Ståhl, Stefan, Löfblom, John, Orlova, Anna
Publicado 2019

Cyclic versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression

por Summer, Dominik, Garousi, Javad, Oroujeni, Maryam, Mitran, Bogdan, Andersson, Ken G., Vorobyeva, Anzhelika, Löfblom, John, Orlova, Anna, Tolmachev, Vladimir, Decristoforo, Clemens
Publicado 2017

Influence of composition of cysteine-containing peptide-based chelators on biodistribution of (99m)Tc-labeled anti-EGFR affibody molecules

por Oroujeni, Maryam, Andersson, Ken G., Steinhardt, Xenia, Altai, Mohamed, Orlova, Anna, Mitran, Bogdan, Vorobyeva, Anzhelika, Garousi, Javad, Tolmachev, Vladimir, Löfblom, John
Publicado 2018